Clin2
NCT06056583Possibly a fitRecruiting

How cimetidine passes into breast milk

PostpartumLactationDrugs in Breast MilkMammary Drug TransportersBCRPOCT1

Part of Women’s health & pregnancy clinical trials.

This study looks at how the drug cimetidine gets into breast milk after healthy mothers take it. The goal is to find out how much reaches the baby and how it affects their body.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
2 weeks to 50 years
Study type
Interventional

Who can take part

  • You are a healthy mother who gave birth recently and is breastfeeding.
  • You are between 18 and 50 years old, and your baby is also part of the study.
  • You can fast (not eat) for at least 4 hours before each study visit.
  • You do not smoke or use any nicotine products.
  • You are not currently taking certain medications that could affect the study results.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07346716Recruiting
Medicines in breast milk and infant exposure

This trial studies how medicines you take while breastfeeding get into your breast milk and what that might mean for your baby. It could help you understand if your medication is safe while nursing.

Copenhagen
NCT07612267Recruiting· Phase 4
Mirikizumab Levels in Breast Milk During Treatment

This study measures how much of the medication mirikizumab passes into breast milk when mothers take it for their approved medical condition. The goal is to understand if it's safe for breastfeeding infants when mothers are receiving this treatment.

Glenview, Illinois
NCT07645235Not yet recruiting· Phase 1
Gepotidacin in Breast Milk of Lactating Women

This study measures how much of an antibiotic called gepotidacin passes into breast milk. Researchers will give healthy breastfeeding women a single dose and collect milk samples to understand if it's safe for nursing infants.

NCT03511118Recruiting
Drug safety study for breastfeeding mothers and babies

This study measures how common medicines move through a breastfeeding parent’s milk and checks safety in both the parent and breastfed baby. It may help doctors use these medicines more safely while you continue breastfeeding.

La Jolla, California
NCT07153159Recruiting· Phase 1
How etrasimod enters breast milk in healthy breastfeeding women

This study looks at how the medication etrasimod gets into breast milk after a single dose. If you are a healthy breastfeeding woman at least 12 weeks after giving birth, you may be able to help researchers understand this process. You would need to stop breastfeeding temporarily for 21 days.

Brussels, Bruxelles-capitale, Région de
NCT06961747Recruiting· Phase 1
Zilucoplan levels in breast milk of healthy nursing mothers

This study measures how much of the drug zilucoplan passes into breast milk. Healthy nursing mothers who are already planning to stop breastfeeding can take part to help understand how the drug is processed.

San Antonio, Texas

Hear when a new Postpartum trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.